Prognostic value of RecurIndex in differentiating HER2-low from HER2-negative early-stage breast cancer: a comprehensive clinicopathologic and molecular analysis in Chinese patients.

Transl Breast Cancer Res · 2026 · PMC12885771 · PMID 41675005

Europe PMC DOI

hedged sentences

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

Although adjuvant radiotherapy showed a trend toward improved survival, the differences did not reach statistical significance.

also in 111,027 other papers

showed a trendno p-value reported

It showed a trend toward higher RFS in HER2-low patients compared to HER2-zero patients in the overall population ( Figure 4A , 84.8% vs. 69.9%; hazard ratio =0.39; 95% CI: 0.1316–1.105; P=0.13).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.